Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a checkpoint inhibitor

Combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a checkpoint inhibitor

US Patent 11951182 · Granted Apr 9, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Trocars2023
Combination therapy using REIC/Dkk-3 gene and a checkpoint inhibitor2022
Antibody that specifically recognizes and binds to REIC/Dkk-3 protein having act2020
Conditionally replicating adenovirus to express REIC gene2018
Partial region polypeptide of REIC/Dkk-3 protein2017
System for increasing gene expression and vector comprising the system2016
Direct administration of REIC/Dkk-3 to mesothelioma2016
Primer and probe for detecting chlamydia trachomatis, and method for detecting c2016
REIC-expressing adenovirus vector2015
Cancer cell death inducing agent having effects of potentiating anticancer drug 2015
Apoptosis-inducing agent for prostate cancer cells2014
Therapeutic agent for malignant mesothelioma and immunostimulant2014